Media type: E-Article Title: A nonribosomal peptide synthetase involved in the biosynthesis of ampullosporins in Sepedonium ampullosporum Contributor: Reiber, Kathrin; Neuhof, Torsten; Ozegowski, Jörg H.; Döhren, Hans von; Schwecke, Torsten Published: Wiley, 2003 Published in: Journal of Peptide Science, 9 (2003) 11-12, Seite 701-713 Language: English DOI: 10.1002/psc.529 ISSN: 1099-1387; 1075-2617 Keywords: Organic Chemistry ; Drug Discovery ; Pharmacology ; Molecular Biology ; Molecular Medicine ; General Medicine ; Biochemistry ; Structural Biology Origination: Footnote: Description: AbstractRecently, the saprophytic ascomycete Sepedonium ampullosporum strain HKI‐0053 was isolated from a basidiomycete on account of its premature induction of pigment formation in Phoma destructiva, a process often related to the neuroleptic activity of the inducing compound. The active substance was identified as the 15‐membered peptaibol type peptide Ampullosporin. Although to date more than 300 peptaibols have been discovered, their biosynthetic machinery has not been characterized yet. By improving the culture conditions it was possible to grow S. ampullosporum in a submerged culture and to increase Ampullosporin production by more than three times to 33 mg/l at reduced fermentation times. The appearance of two high molecular weight proteins, HMWP1 (1.5 MDa) and HMWP2 (350 kDa) was closely related to the production of Ampullosporin during the course of fermentation. Both proteins showed a cross‐reaction with antibodies against a core fragment of nonribosomal peptide synthetases (NRPSs). Biochemical characterization of the partially purified enzymes exhibited selectivity for the substrate amino acid α‐aminoisobutyric acid (Aib), substantiating their involvement in Ampullosporin biosynthesis. Our data suggest that Ampullosporin synthetase has been isolated, and provides the basis for the characterization of the entire biosynthetic gene cluster. Furthermore, this knowledge will enable the manipulation of its NRPS template, in order to engineer mutant strains of Sepedonium ampullosporum which could produce more potent analogues of Ampullosporin. Copyright © 2003 European Peptide Society and John Wiley & Sons, Ltd.